Overview
- 12 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-11-14.
At a glance
Inspections
12
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 10 Nov 2025 – 14 Nov 2025 | Human Drugs | 483 | On file |
| 24 Apr 2023 – 28 Apr 2023 | Human Drugs | Clean | |
| 23 Jan 2023 – 25 Jan 2023 | Human Drugs | Clean | |
| 20 Jan 2020 – 24 Jan 2020 | Human Drugs | 483 | View 483 → |
| 29 Apr 2019 – 3 May 2019 | Human Drugs | Clean | |
| 11 Mar 2019 – 15 Mar 2019 | Human Drugs | Clean | |
| 9 Jul 2018 – 13 Jul 2018 | Human Drugs | 483 | View 483 → |
| 14 Aug 2017 – 18 Aug 2017 | Human Drugs | 483 | View 483 → |
| 16 Aug 2016 – 26 Aug 2016 | Human Drugs | Clean | |
| 12 Oct 2015 – 16 Oct 2015 | Human Drugs | 483 | On file |
| 10 Jun 2013 – 14 Jun 2013 | Human Drugs | Clean | |
| 15 Apr 2010 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
24 Jan 2020
21 CFR 211.186(b)(9)
Complete instructions, procedures, specifications et. al.
Cited by Liming Zhang
24 Jan 2020
21 CFR 211.186(b)(9)
Complete instructions, procedures, specifications et. al.
Cited by Liming Zhang
Investigators
FDA investigators tied to this site in the record.
Sylvestre K Dossou1 insp.
Patty P Kaewussdangkul1 insp.
Sheri L Stephenson1 insp.
Liming Zhang1 insp.
Courtney N Long1 insp.
Makini Cobourne-Duval1 insp.
Hasan A Irier1 insp.
Jose O Hernandez1 insp.
Saleem A Akhtar1 insp.
Scott B Laufenberg1 insp.
Luis A Dasta1 insp.
Barbara A Rusin1 insp.
Gale L Glinecki1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.170(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.52 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
Full site report
Get the verbatim findings behind Aizant Drug Research Solutions Private Ltd.'s 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat